SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091808
Filing Date
2024-08-06
Accepted
2024-08-06 16:11:05
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20240630.htm   iXBRL 10-Q 3175450
2 EX-10.2 fgen-ex10_2.htm EX-10.2 588163
3 EX-10.3 fgen-ex10_3.htm EX-10.3 1039396
4 EX-10.4 fgen-ex10_4.htm EX-10.4 87371
5 EX-10.5 fgen-ex10_5.htm EX-10.5 111465
6 EX-31.1 fgen-ex31_1.htm EX-31.1 9310
7 EX-31.2 fgen-ex31_2.htm EX-31.2 9298
8 EX-32.1 fgen-ex32_1.htm EX-32.1 8765
9 GRAPHIC img86529339_0.jpg GRAPHIC 12867
10 GRAPHIC img86529339_1.jpg GRAPHIC 7426
  Complete submission text file 0000950170-24-091808.txt   13692576

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240630.xsd EX-101.SCH 1729151
84 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240630_htm.xml XML 1941900
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 241179332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)